Clinical Benefit-Risk Profile of Lenalidomide in Patients With Lower-risk Myelodysplastic Syndromes Without del(5q): Results of a Phase III Trial

Guillermo Garcia-Manero, Antonio Almeida, Pierre Fenaux, Norbert Gattermann, Aristoteles Giagounidis, Stuart L. Goldberg, Keiya Ozawa, Jerry Weaver, Valeria Santini

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical Benefit-Risk Profile of Lenalidomide in Patients With Lower-risk Myelodysplastic Syndromes Without del(5q): Results of a Phase III Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences